CBN Produced THC-Like Drug Cues in Mice Without Establishing Human Equivalence
Cannabinol, or CBN, produced THC-like discriminative cues and adaptation with repeated exposure in a mouse study. That does not establish that CBN and THC have identical effects, potency or risks in people.
What a discrimination task measures
One cohort was trained to distinguish THC from vehicle. CBN fully substituted for THC in that task, meaning its internal drug cue was sufficiently similar to produce the trained response. This is an animal behavioral classification, not a direct report that a person felt the same high.
Repeated exposure produced adaptation
Other mice received CBN repeatedly and underwent tests of movement-related, temperature and antinociceptive effects. The abstract reports tolerance to several CBN effects and cross-tolerance to WIN55,212-2. Rimonabant subsequently elicited withdrawal-related physical signs in CBN-treated animals.
Antagonist-precipitated signs have a specific meaning
Giving a receptor antagonist can reveal adaptation by abruptly opposing cannabinoid signaling. That procedure differs from observing what happens when a person simply stops using a retail product. It cannot determine the frequency or severity of spontaneous CBN withdrawal in humans.
The study also reported a change in THC's discriminative effect when CBN was coadministered. That result does not establish protection against driving impairment or toxicity. Species, administered doses, product composition and the selected behavioral endpoints all constrain translation. CBN should be evaluated on its own evidence rather than assumed equivalent to THC or assumed incapable of producing adaptation.
Related: interpreting cannabis tolerance claims.
Research cited
Vanegas SO; Marusich JA; Maturano J; Sarlah D; Kinsey SG. Tolerance, physical dependence, and Δ9-THC-like interoceptive effects of cannabinol in mice. Drug and alcohol dependence (2026). doi:10.1016/j.drugalcdep.2026.113341. Findings discussed from the study abstract.
